Amicus Therapeutics, Inc. (NASD:FOLD) was a big mover last session, as the company saw its shares rise by roughly 11% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend of the company as the stock has now gained over 20% since Jan 13.
This biotechnology company has seen no estimate revision over the past 30 days and its Zacks Consensus Estimate remained unchanged over the same time frame. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Amicus Therapeutics currently has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.
Some better-ranked stocks in the same industry include Actelion Ltd. (OTC:ALIOF), Affymetrix Inc. (NASD:AFFX) and Alimera Sciences, Inc. (NASD:ALIM). All these stocks hold a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
AMICUS THERAPEUTICS INC (FOLD): Free Stock Analysis Report
ACTELION LTD (ALIOF): Free Stock Analysis Report
AFFYMETRIX INC (AFFX): Free Stock Analysis Report
ALIMERA SCIENCES INC (ALIM): Free Stock Analysis Report
Zacks Investment Research